Close

CymaBay Therapeutics (CBAY) Announces Clinically Meaningful Data from MBX-8025 Phase 2 in HoFH

Go back to CymaBay Therapeutics (CBAY) Announces Clinically Meaningful Data from MBX-8025 Phase 2 in HoFH

CymaBay Therapeutics (CBAY) to Resume Trading at 4:30 PM ET

March 17, 2016 4:30 PM EDT

CymaBay Therapeutics (NASDAQ: CBAY) to Resume Trading at 4:30 PM ET

... More